This solicitation closed on May 29, 2026
View current DEFENSE HEALTH AGENCY (DHA) opportunities →Chemoinformatic Platform
AI Overview
Market research for web-based chemoinformatic platform software supporting drug development, chemical reactions, drug metabolism research, and IP prior art analysis at USAMRIID.
This summary is AI-generated from the official solicitation.
Key Details
Official Description
Request for Information (RFI)/Sources Sought (SS) Notice Requiring Activity Name: The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) Subject: This is a non-personal service(s) contract to contract mechanisms to supply a web-based chemoinformatic platform software license. This chemoinformatic platform is required to conduct state-of-the-art chemical research including drug development, chemical reactions, drug metabolism, and knowledge of prior art for intellectual proper...
Change History
Chemoinformatic Platform
New SAM.gov opportunity: Chemoinformatic Platform
Similar Opportunities
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial